P75.16 Real-World Data from a Spanish Institution

Abstract

Performance Status ECOG. Despite the small number of G3 toxicities our findings underline the trend to a different toxicity profile related to gender, as generally reported in previous studies. Females seem to develop serious hepatic /gastrointestinal and skin immune-related side effects more frequently as compared to males and with a shorter time onset. Our observations support further investigation about genderrelated outcomes in clinical trials, helping to better understand the impact of sex on efficacy and safety of immune checkpoint inhibitors treatment, thus improving the patients' management